Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMERI.L Regulatory News (MERI)

  • There is currently no data for MERI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

27 Nov 2020 15:02

RNS Number : 8083G
Merian Chrysalis Investment Co. Ltd
27 November 2020
 

THE INFORMATION CONTAINED IN THIS ANNOUNCEMENT IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION IN THE UNITED STATES OF AMERICA, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE UNITED KINGDOM AND THE REPUBLIC OF IRELAND), CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

27 November 2020

Merian Chrysalis Investment Company Limited (the "Company")

Director/PDMR shareholding

The Company wishes to announce in accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation the following dealing in the Company's ordinary shares of no-par value by persons discharging managerial responsibility:

 

 

Details of the person discharging managerial responsibilities/person closely associated

Name

Samuel Cruttenden

 

 

Reason for the notification

 

Position/status

PCA (Son of Tim Cruttenden - Independent Director of the Board)

 

Initial Notification / Amendment

Initial Notification

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Merian Chrysalis Investment Company Limited

LEI

213800F9SQ753JQHSW24

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument,

type of

instrument

Identification code

Ordinary shares of no par value

 

ISIN: GG00BGJYPP46

Nature of the transaction

Purchase

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

144.84p

6,370

 

Aggregated information

- Aggregated volume

- Price

 

N/A (Single Transaction)

 

Date of the transaction

27 November 2020

 

Place of the transaction

LONDON STOCK EXCHANGE, (XLON)

 

Additional Information

 

 

This announcement is made in accordance with the requirements of the EU Market Abuse Regulation ("MAR") and the Company confirms that the PDMR's notification obligations under MAR have also been satisfied.

For further information, please contact:

 

Merian Global Investors:

Amelie Shepherd

 

 

+44 (0) 20 7332 7500

Liberum:

Gillian Martin / Owen Matthews

 

 

+44 (0) 20 3100 2000

Maitland Administration (Guernsey) Limited:

Elaine Smeja / Aimee Gontier

 

+44 (0) 1481 749360

 

 

A copy of the Prospectus is available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism as well as on the Company's website at www.merian.com/chrysalis.

 

A copy of this announcement will be available on the Company's website at www.Merian.com/Chrysalis. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

Terms used but not defined in this announcement shall have the meanings given to such terms in the Prospectus.

 

LEI: 213800F9SQ753JQHSW24

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBSBDBCUDDGGR
Date   Source Headline
19th Mar 202012:09 pmRNSSecond Price Monitoring Extn
19th Mar 202012:03 pmRNSPrice Monitoring Extension
18th Mar 20202:51 pmRNSDirector/PDMR Shareholding
13th Mar 20207:00 amRNSNet Asset Value(s)
9th Mar 20204:36 pmRNSPrice Monitoring Extension
28th Feb 20204:05 pmRNSResult of AGM
17th Feb 20203:11 pmRNSCorporate Update
30th Jan 20207:00 amRNSNotice of AGM
24th Jan 20207:00 amRNSFinal Results
15th Jan 20203:46 pmRNSAppointment of Senior Independent Director
15th Jan 20207:00 amRNSPortfolio Update
11th Dec 20197:00 amRNSPortfolio Update
3rd Dec 20197:00 amRNSNet Asset Value(s)
27th Nov 20197:00 amRNSPortfolio Update
23rd Oct 20197:00 amRNSPortfolio Update
1st Oct 20199:21 amRNSHolding(s) in Company
27th Sep 20194:49 pmRNSHolding(s) in Company
27th Sep 20193:47 pmRNSHolding(s) in Company
27th Sep 20193:46 pmRNSHolding(s) in Company
27th Sep 201912:46 pmRNSHolding(s) in Company
27th Sep 20197:00 amRNSHolding(s) in Company
26th Sep 20198:00 amRNSPDMR shareholdings
25th Sep 20193:16 pmRNSHolding(s) in Company
25th Sep 20193:12 pmRNSDirector Declaration
24th Sep 20197:00 amRNSResult of Placing under Placing Programme
20th Sep 20197:00 amRNSPlacing Update
18th Sep 20197:00 amRNSAnnouncement of Placing Price
10th Sep 20197:00 amRNSPlacing under Placing Programme
30th Aug 20197:00 amRNSNet Asset Value(s)
16th Aug 20197:00 amRNSPortfolio Update
6th Aug 20192:20 pmRNSPortfolio Update
4th Jul 20197:00 amRNSPortfolio Update
28th Jun 20196:31 pmRNSHalf-year Report
20th Jun 20197:00 amRNSCorporate Update
31st May 20197:00 amRNSNet Asset Value(s)
7th May 20193:55 pmRNSHolding(s) in Company
26th Apr 20193:36 pmRNSHolding(s) in Company
24th Apr 20191:10 pmRNSHolding(s) in Company
24th Apr 20191:08 pmRNSHolding(s) in Company
24th Apr 20191:06 pmRNSHolding(s) in Company
18th Apr 20194:52 pmRNSDirector/PDMR Shareholding
18th Apr 20191:43 pmRNSHolding(s) in Company
16th Apr 20197:00 amRNSResult of Placing under Placing Programme
15th Apr 20197:00 amRNSPlacing Update
12th Apr 20198:46 amRNSProposed Placing Price
12th Apr 20198:45 amRNSPortfolio Update
26th Mar 20197:00 amRNSPlacing under Placement Programme
5th Mar 20197:00 amRNSNAV Announcement and Portfolio Update
22nd Feb 20191:22 pmRNSStarling Bank awarded CIF Pool A grant
13th Feb 20197:00 amRNSPortfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.